{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:52:48Z","timestamp":1793332368742,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.bbi.2022.01.002","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T11:33:12Z","timestamp":1641468792000},"page":"136-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"special_numbering":"C","title":["Peripheral and central kynurenine pathway abnormalities in major depression"],"prefix":"10.1016","volume":"101","author":[{"given":"Elisabeth R.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly","family":"Schwieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Erhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Boda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Trepci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"K\u00e4mpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Asratian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovisa","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Yngve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dantzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Heilig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Paul","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Samuelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2022.01.002_b0005","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders. 5th edn: Washington, DC.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.bbi.2022.01.002_b0010","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.neubiorev.2018.05.031","article-title":"Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies","volume":"92","author":"Arnone","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.bbi.2022.01.002_b0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/jnnp-2019-320912","article-title":"Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials","volume":"91","author":"Bai","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2022.01.002_b0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0306-4522(94)90438-3","article-title":"Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry","volume":"61","author":"Beninger","year":"1994","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.bbi.2022.01.002_b0025","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1128\/AAC.37.11.2422","article-title":"Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans","volume":"37","author":"Blasi","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbi.2022.01.002_b0030","doi-asserted-by":"crossref","unstructured":"Brundin L, Sellgren CM, Lim CK, Grit J, Palsson E, Landen M et al. 2016. An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation. Transl. Psychiatry, 6(8): e865.","DOI":"10.1038\/tp.2016.133"},{"issue":"4","key":"10.1016\/j.bbi.2022.01.002_b0035","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1176\/appi.ajp.161.4.598","article-title":"Lower hippocampal volume in patients suffering from depression: a meta-analysis","volume":"161","author":"Campbell","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2022.01.002_b0040","unstructured":"Cinar O, Viechtbauer W. 2016. PoolR: Package for pooling the results from (dependent) tests."},{"issue":"2","key":"10.1016\/j.bbi.2022.01.002_b0045","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/pcn.12944","article-title":"Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study","volume":"74","author":"Colle","year":"2020","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2022.01.002_b0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2022.01.002_b0055","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","article-title":"Inflammation-associated depression: from serotonin to kynurenine","volume":"36","author":"Dantzer","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2022.01.002_b0060","doi-asserted-by":"crossref","unstructured":"Derringer J. 2018. A simple correction for non-independent tests.","DOI":"10.31234\/osf.io\/f2tyw"},{"key":"10.1016\/j.bbi.2022.01.002_b0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.psyneuen.2018.05.019","article-title":"Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes","volume":"95","author":"Doolin","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.bbi.2022.01.002_b0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2022.01.002_b0075","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1073\/pnas.1914655117","article-title":"Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression","volume":"117","author":"Dudek","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2022.01.002_b0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","article-title":"Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue","volume":"81","author":"Enache","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2022.01.002_b0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-201X.2002.00962.x","article-title":"Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid","volume":"175","author":"Erhardt","year":"2002","journal-title":"Acta Physiol. Scand."},{"issue":"5","key":"10.1016\/j.bbi.2022.01.002_b0090","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/npp.2012.248","article-title":"Connecting inflammation with glutamate agonism in suicidality","volume":"38","author":"Erhardt","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.bbi.2022.01.002_b0095","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2022.01.002_b0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4137\/IJTR.S2469","article-title":"The physiological action of picolinic Acid in the human brain","volume":"2","author":"Grant","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"issue":"1","key":"10.1016\/j.bbi.2022.01.002_b0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41398-020-01054-3","article-title":"Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders","volume":"10","author":"Greene","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbi.2022.01.002_b0110","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J."},{"issue":"47","key":"10.1016\/j.bbi.2022.01.002_b0115","doi-asserted-by":"crossref","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","article-title":"Characterization of the kynurenine pathway in human neurons","volume":"27","author":"Guillemin","year":"2007","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.bbi.2022.01.002_b0120","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/mp.2008.57","article-title":"Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies","volume":"13","author":"Hamilton","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2022.01.002_b0125","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41386-020-0607-1","article-title":"Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression","volume":"45","author":"Haroon","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbi.2022.01.002_b0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jnc.14599","article-title":"The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease","volume":"148","author":"Harrison","year":"2019","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bbi.2022.01.002_b0135","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1471-4159.1997.68010280.x","article-title":"Quantification of local de novo synthesis versus blood contributions to quinolinic acid concentrations in brain and systemic tissues","volume":"68","author":"Heyes","year":"1997","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.bbi.2022.01.002_b0140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41593-018-0326-7","article-title":"Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions","volume":"22","author":"Howard","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2022.01.002_b0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-81306-4","article-title":"Differential effects on blood and cerebrospinal fluid immune protein markers and kynurenine pathway metabolites from aerobic physical exercise in healthy subjects","volume":"11","author":"Isung","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2022.01.002_b0150","doi-asserted-by":"crossref","first-page":"134576","DOI":"10.1016\/j.neulet.2019.134576","article-title":"Impaired metabolism of kynurenine and its metabolites in CSF of parkinson's disease","volume":"714","author":"Iwaoka","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2022.01.002_b0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.03.015","article-title":"Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-beta and tau","volume":"80","author":"Jacobs","year":"2019","journal-title":"Neurobiol. Aging"},{"issue":"2-3","key":"10.1016\/j.bbi.2022.01.002_b0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03033790","article-title":"Excitotoxicity of quinolinic acid: modulation by endogenous antagonists","volume":"2","author":"Jhamandas","year":"2000","journal-title":"Neurotox. Res."},{"issue":"1-2","key":"10.1016\/j.bbi.2022.01.002_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(94)90504-5","article-title":"Picolinic acid protects against quinolinic acid-induced depletion of NADPH diaphorase containing neurons in the rat striatum","volume":"668","author":"Kalisch","year":"1994","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bbi.2022.01.002_b0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00702-011-0668-8","article-title":"New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid\/3-hydroxykynurenine ratio","volume":"119","author":"Kocki","year":"2012","journal-title":"J. Neural Transm (Vienna)"},{"issue":"5","key":"10.1016\/j.bbi.2022.01.002_b0175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.bbi.2022.01.002_b0180","first-page":"4195","article-title":"Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis","volume":"55","author":"Kohler","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.bbi.2022.01.002_b0185","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/mp.2012.144","article-title":"Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression","volume":"18","author":"Lamers","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2022.01.002_b0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbi.2020.04.002","article-title":"Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study","volume":"88","author":"Lamers","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2022.01.002_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00246","article-title":"Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis","volume":"7","author":"Lovelace","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2022.01.002_b0200","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2022.01.002_b0205","unstructured":"Mangiafico SS. 2016. Summary and analysis of extension program evaluation in R. Rutgers Cooperative Extension: New Brunswick, NJ, USA, 125: 16-22."},{"key":"10.1016\/j.bbi.2022.01.002_b0210","doi-asserted-by":"crossref","unstructured":"Marx W, McGuinness AJ, Rocks T, Ruusunen A, Cleminson J, Walker AJ et al. (2020). The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies. Mol. Psychiatry.","DOI":"10.1038\/s41380-020-00951-9"},{"key":"10.1016\/j.bbi.2022.01.002_b0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","article-title":"Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder","volume":"53","author":"Meier","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.bbi.2022.01.002_b0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2020.01.014","article-title":"Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression","volume":"88","author":"Milaneschi","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2022.01.002_b0225","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"S2","key":"10.1016\/j.bbi.2022.01.002_b0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00406-008-2012-3","article-title":"A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders","volume":"258","author":"M\u00fcller","year":"2008","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"5-6","key":"10.1016\/j.bbi.2022.01.002_b0235","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","article-title":"Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression","volume":"61","author":"Myint","year":"2003","journal-title":"Med. Hypotheses"},{"issue":"4","key":"10.1016\/j.bbi.2022.01.002_b0240","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/383251","article-title":"A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other","volume":"74","author":"Nyholt","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbi.2022.01.002_b0245","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","article-title":"Kynurenine pathway in depression: A systematic review and meta-analysis","volume":"90","author":"Ogyu","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2022.01.002_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2009.05356.x","article-title":"Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism","volume":"1199","author":"Oxenkrug","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bbi.2022.01.002_b0260","article-title":"Peripheral Tryptophan - Kynurenine Metabolism Associated with Metabolic Syndrome is Different in Parkinson's and Alzheimer's Diseases","volume":"1","author":"Oxenkrug","year":"2017","journal-title":"Endocrinol. Diabetes Metab. J."},{"key":"10.1016\/j.bbi.2022.01.002_b0265","unstructured":"R Development Core Team (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria."},{"key":"10.1016\/j.bbi.2022.01.002_b0270","unstructured":"Rosenthal R, Cooper H, Hedges L. 1994. Parametric measures of effect size. The handbook of research synthesis, 621(2): 231-244."},{"key":"10.1016\/j.bbi.2022.01.002_b0275","unstructured":"RStudio Team. RStudio: (2021). Integrated Development Environment for R. RStudio, PBC: Boston, MA."},{"issue":"20","key":"10.1016\/j.bbi.2022.01.002_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000068","article-title":"Tryptophan metabolism in the central nervous system: medical implications","volume":"8","author":"Ruddick","year":"2006","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.bbi.2022.01.002_b0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2019.10.005","article-title":"Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy","volume":"83","author":"Ryan","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"5276","key":"10.1016\/j.bbi.2022.01.002_b0290","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1126\/science.273.5276.749","article-title":"Why stress is bad for your brain","volume":"273","author":"Sapolsky","year":"1996","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bbi.2022.01.002_b0295","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative Neuroprotective and Neurotoxic Kynurenine Pathway Metabolites Are Associated with Hippocampal and Amygdalar Volumes in Subjects with Major Depressive Disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2022.01.002_b0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","article-title":"Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder","volume":"46","author":"Savitz","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"Pt B","key":"10.1016\/j.bbi.2022.01.002_b0305","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: Challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.bbi.2022.01.002_b0310","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.bbi.2022.01.002_b0315","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1503\/jpn.140126","article-title":"Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia\u2013significance for activation of the kynurenine pathway","volume":"40","author":"Schwieler","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"issue":"6","key":"10.1016\/j.bbi.2022.01.002_b0320","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4155\/bio-2019-0303","article-title":"A novel, robust method for quantification of multiple kynurenine pathway metabolites in the cerebrospinal fluid","volume":"12","author":"Schwieler","year":"2020","journal-title":"Bioanalysis"},{"issue":"10","key":"10.1016\/j.bbi.2022.01.002_b0325","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/mp.2015.186","article-title":"A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder","volume":"21","author":"Sellgren","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2022.01.002_b0330","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry, 59 Suppl 20: 22-33;quiz 34-57."},{"issue":"3","key":"10.1016\/j.bbi.2022.01.002_b0335","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.bbi.2022.01.002_b0340","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-6147(00)01451-6","article-title":"Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection","volume":"21","author":"Stone","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2022.01.002_b0345","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3389\/fnins.2019.01013","article-title":"Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis","volume":"13","author":"Tan","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbi.2022.01.002_b0350","doi-asserted-by":"crossref","unstructured":"Trepci A, Imbeault S, Wyckelsma VL, Westerblad H, Hermansson S, Andersson DC et al. 2020. Quantification of Plasma Kynurenine Metabolites Following One Bout of Sprint Interval Exercise. Int. J. Tryptophan Res. 13: 1178646920978241.","DOI":"10.1177\/1178646920978241"},{"issue":"10","key":"10.1016\/j.bbi.2022.01.002_b0355","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archgenpsychiatry.2010.125","article-title":"Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study","volume":"67","author":"Umhau","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"11","key":"10.1016\/j.bbi.2022.01.002_b0360","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1176\/appi.ajp.161.11.1957","article-title":"Hippocampal volume and depression: a meta-analysis of MRI studies","volume":"161","author":"Videbech","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2022.01.002_b0365","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0006-8993(93)90320-M","article-title":"Picolinic acid modulates kainic acid-evoked glutamate release from the striatum in vitro","volume":"627","author":"Vrooman","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2022.01.002_b0370","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.bbi.2022.01.002_bib372","series-title":"ICD-10\u202f: international statistical classification of diseases and related health problems","author":"World Health Organization (WHO)","year":"2004"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159122000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159122000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:16:32Z","timestamp":1760170592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159122000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":74,"alternative-id":["S0889159122000022"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2022.01.002","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral and central kynurenine pathway abnormalities in major depression","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2022.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}